Almirall and Galapagos' BioFocus subsidiary partnered to discover and develop drugs against an undisclosed respiratory target

Almirall S.A.

Spain / Small-Cap Biopharma (<$1 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Galapagos N.V.

Belgium / Small-Cap Biopharma (<$1 billion)

$364.2m on 01/27/2012 [market cap]

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced